Back to Journals » International Journal of Women's Health » Volume 9

Updated approaches for management of uterine fibroids

Authors Mas A, Tarazona M, Dasí Carrasco J, Estaca G, Cristóbal I, Monleón J

Received 6 April 2017

Accepted for publication 10 June 2017

Published 5 September 2017 Volume 2017:9 Pages 607—617


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Editor who approved publication: Professor Elie Al-Chaer

Aymara Mas,1,2 Marta Tarazona,3 Joana Dasí Carrasco,3 Gloria Estaca,4,5 Ignacio Cristóbal,4,5 Javier Monleón3

1Reproductive Medicine Research Group, Institute of Health Research La Fe, University and Polytechnic Hospital La Fe, Valencia, Spain; 2Research and Development Department, Igenomix Foundation, Valencia, Spain; 3Gynecology Department, University and Polytechnic Hospital La Fe, Valencia, Spain; 4Obstetrics and Gynecology Department, La Zarzuela Hospital, Madrid, Spain; 5Obstetrics and Gynecology Department, Universidad Francisco de Vitoria, Madrid, Spain

Abstract: Uterine anatomy and uterine fibroids (UFs) characteristics have been classically considered as almost a unique issue in gynecology and reproductive medicine. Nowadays, the management of UF pathology is undergoing an important evolution, with the patient’s quality of life being the most important aspect to consider. Accordingly, surgical techniques and aggressive treatments are reserved for only those cases with heavy symptomatology, while the clinical diagnostic based on size and number of UFs remains in a second plane in these situations. Moreover, the development of several noninvasive surgical techniques, especially the appearance of ulipristal acetate as a medical etiological treatment, has substantially changed the clinical indications. As a consequence, after almost 2 decades without relevant updates, it has been necessary to update the protocols for the management of UFs in the Spanish Society of Gynecology and Obstetrics twice. Accordingly, we believe that it is necessary to translate our experience to protocolize the medical care for patients with UFs, incorporating these new therapeutic options, and selecting the best treatment for them. We highlight the importance of achieving the patient’s goals and decisions by improving the clinical diagnosis for these type of pathologies, allowing enhanced personalized treatments, as well as the reduction of potential risks and unnecessary surgeries.

Keywords: uterine fibroids, UFs, selective progesterone receptor modulator, sPRM, ulipristal acetate, UPA

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]